[
    [
        {
            "time": "",
            "orginal_text": "中信建投医药 | 行业周报】业绩真空期，继续配置高性价比品种",
            "features": {
                "keywords": [
                    "中信建投",
                    "医药",
                    "行业周报",
                    "业绩真空期",
                    "高性价比"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "中信建投医药 | 行业周报】业绩真空期，继续配置高性价比品种",
            "scores": {
                "News_content": "中信建投医药 | 行业周报】业绩真空期，继续配置高性价比品种",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "三个月千亿外资已入场，扫货消费、科技，42股买入超2%",
            "features": {
                "keywords": [
                    "外资",
                    "入场",
                    "消费",
                    "科技",
                    "买入"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "三个月千亿外资已入场，扫货消费、科技，42股买入超2%",
            "scores": {
                "News_content": "三个月千亿外资已入场，扫货消费、科技，42股买入超2%",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 10,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "基石药业3年半亏损超36亿 抗癌神药如何破解价格战 亏损",
            "features": {
                "keywords": [
                    "基石药业",
                    "亏损",
                    "抗癌神药",
                    "价格战"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "基石药业3年半亏损超36亿 抗癌神药如何破解价格战 亏损",
            "scores": {
                "News_content": "基石药业3年半亏损超36亿 抗癌神药如何破解价格战 亏损",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "药明康德(02359-HK)回购合计338,349股限制性A股",
            "features": {
                "keywords": [
                    "药明康德",
                    "回购",
                    "限制性A股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "药明康德(02359-HK)回购合计338,349股限制性A股",
            "scores": {
                "News_content": "药明康德(02359-HK)回购合计338,349股限制性A股",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "医药行业周报: 病理免疫组化为被市场遗忘的“小化学发光”",
            "features": {
                "keywords": [
                    "医药行业",
                    "周报",
                    "病理免疫组化",
                    "小化学发光"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "original_text": "医药行业周报: 病理免疫组化为被市场遗忘的“小化学发光”",
            "scores": {
                "News_content": "医药行业周报: 病理免疫组化为被市场遗忘的“小化学发光”",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]